Eye - Table of Contents alert Volume 29 Issue 9

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 29, Issue 9 (September 2015) In this issue Reviews Clinical Studies Laboratory Study Case Series Correspondence Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement SUBMIT TO EYE Submit your research to Eye and enjoy a wide range of benefits, including: Fast Track Review Hosted on nature.com with 9.4 million unique users per month Monthly average of 5,000 webpage views and 100,000+ full text article views 40,000+ eAlert registrants Find out how to submit your research today   Reviews Top A review of therapies for diabetic macular oedema and rationale for combination therapy W M K Amoaku, S Saker and E A Stewart Eye 2015 29: 1115-1130; advance online publication, June 26, 2015; 10.1038/eye.2015.110 Abstract | Full Text New and emerging technologies for the treatment of inherited retinal diseases: a horizon scanning review OPEN J Smith, D Ward, M Michaelides, A T Moore and S Simpson Eye 2015 29: 1131-1140; advance online publication, June 26, 2015; 10.1038/eye.2015.115 Abstract | Full Text Clinical Studies Top Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration H S Kim, H J Cho, S G Yoo, J H Kim, J I Han, T G Lee and J W Kim Eye 2015 29: 1141-1151; advance online publication, August 14, 2015; 10.1038/eye.2015.131 Abstract | Full Text Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results N Homer, D S Grewal, R G Mirza, A T Lyon and M K Gill Eye 2015 29: 1152-1155; advance online publication, May 29, 2015; 10.1038/eye.2015.87 Abstract | Full Text Long-term visual outcomes of intravitreal ranibizumab treatment for wet age-related macular degeneration and effect on blindness rates in south-east Scotland S Borooah, V S Jeganathan, A-M Ambrecht, D Oladiwura, M Gavin, B Dhillon and P Cackett Eye 2015 29: 1156-1161; advance online publication, June 5, 2015; 10.1038/eye.2015.83 Abstract | Full Text A 10-year review of orbital biopsy: the Newcastle Eye Centre Study D S J Ting, M Perez-Lopez, N J Chew, L Clarke, A J Dickinson and C Neoh Eye 2015 29: 1162-1166; advance online publication, June 5, 2015; 10.1038/eye.2015.95 Abstract | Full Text Cup-to-disc and arteriole-to-venule ratios in preterm birth J Kim, D Y Choi, K-A Park and S Y Oh Eye 2015 29: 1167-1172; advance online publication, June 19, 2015; 10.1038/eye.2015.99 Abstract | Full Text Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants OPEN Y Yang, C Bailey, F G Holz, N Eter, M Weber, C Baker, S Kiss, U Menchini, J M Ruiz Moreno, P Dugel and A Lotery on behalf of the FAME study group Eye 2015 29: 1173-1180; advance online publication, June 26, 2015; 10.1038/eye.2015.98 Abstract | Full Text Comparison of two- and three-point sutures for advancing the levator aponeurosis in Asian eyelids Y S Kim, J S Yoon and S Y Jang Eye 2015 29: 1181-1185; advance online publication, June 26, 2015; 10.1038/eye.2015.107 Abstract | Full Text Spectral-domain optical coherence tomography analysis of persistent subretinal fluid after scleral buckling surgery for macula-off retinal detachment M Gharbiya, R Malagola, C Mariotti, F Parisi, U De Vico, C Ganino and F Grandinetti Eye 2015 29: 1186-1193; advance online publication, July 3, 2015; 10.1038/eye.2015.113 Abstract | Full Text Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma M J Sikuade, S Salvi, P A Rundle, D G Errington, A Kacperek and I G Rennie Eye 2015 29: 1194-1198; advance online publication, July 10, 2015; 10.1038/eye.2015.109 Abstract | Full Text Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy K Ghasemi Falavarjani, M Modarres, A Hadavandkhani and A Karimi Moghaddam Eye 2015 29: 1199-1203; advance online publication, July 10, 2015; 10.1038/eye.2015.114 Abstract | Full Text Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren’s syndrome N Yokoi, Y Sonomura, H Kato, A Komuro and S Kinoshita Eye 2015 29: 1204-1212; advance online publication, July 10, 2015; 10.1038/eye.2015.125 Abstract | Full Text Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment M S Dikopf, K H Patel, V J Setlur and J I Lim Eye 2015 29: 1213-1219; advance online publication, July 17, 2015; 10.1038/eye.2015.126 Abstract | Full Text Effect of laser suture lysis on filtration openings: a prospective three-dimensional anterior segment optical coherence tomography study H-k Cho, S Kojima, T Inoue, A Fukushima, C Kee and H Tanihara Eye 2015 29: 1220-1225; advance online publication, July 24, 2015; 10.1038/eye.2015.129 Abstract | Full Text Laboratory Study Top Diverse clinical phenotypes associated with a nonsense mutation in FAM161A A M Rose, P Sergouniotis, G Alfano, N Muspratt-Tucker, S Barton, A T Moore, G Black, S S Bhattacharya and A R Webster Eye 2015 29: 1226-1232; advance online publication, June 26, 2015; 10.1038/eye.2015.93 Abstract | Full Text Case Series Top SSRI-associated optic neuropathy J Lochhead Eye 2015 29: 1233-1235; advance online publication, July 3, 2015; 10.1038/eye.2015.119 Abstract | Full Text Correspondence Top Intravitreal aflibercept for choroidal neovascularisation in angioid streaks S Vaz-Pereira, L Collaço, G De Salvo and P van Zeller Eye 2015 29: 1236-1238; advance online publication, May 29, 2015; 10.1038/eye.2015.92 Full Text Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab C S Tan, W K Ngo, L W Lim and T H Lim Eye 2015 29: 1238; advance online publication, June 19, 2015; 10.1038/eye.2015.101 Full Text Reply to ‘Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab’ M Ho, E C Lo, A L Young and D T L Liu Eye 2015 29: 1239; advance online publication, June 19, 2015; 10.1038/eye.2015.102 Full Text Corrigendum Top Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants Y Yang, C Bailey, F G Holz, N Eter, M Weber, C Baker, S Kiss, U Menchini, J M Ruiz Moreno, P Dugel and A Lotery on behalf of the FAME study group Eye 2015 29: 1240; 10.1038/eye.2015.145 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Eye. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.